Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6151
CALL
Applied Industrial Technologies
AIT
$13.3B
| $671K | ﹤0.01% |
10,900
-2,300
| -17% | -$134K |
|
6152
CALL
Columbia Sportswear
COLM
$2.94B
| $671K | ﹤0.01% |
6,700
+900
| +16% | +$89.3K |
|
6153
Groupon
GRPN
$875M
| $671K | ﹤0.01% |
9,375
-4,075
| -30% | -$288K |
|
|
LTHM
6154
PUT
DELISTED
Livent Corporation
LTHM
| $671K | ﹤0.01% |
97,000
+61,800
| +176% | +$555K |
|
|
DCP
6155
PUT
DELISTED
DCP Midstream, LP
DCP
| $671K | ﹤0.01% |
22,900
-21,100
| -48% | -$659K |
|
6156
PUT
Lamar Advertising Co
LAMR
$15.8B
| $670K | ﹤0.01% |
8,300
-5,300
| -39% | -$428K |
|
6157
CALL
Badger Meter
BMI
$3.79B
| $669K | ﹤0.01% |
11,200
+3,900
| +53% | +$216K |
|
6158
PUT
TG Therapeutics
TGTX
$7.46B
| $669K | ﹤0.01% |
77,300
-17,200
| -18% | -$130K |
|
|
ANSS
6159
DELISTED
Ansys
ANSS
| $668K | ﹤0.01% |
3,260
-90,981
| -97% | -$17.3M |
|
6160
Blue Bird Corp
BLBD
$2.05B
| $667K | ﹤0.01% |
33,877
+13,755
| +68% | +$252K |
|
6161
PUT
Corcept Therapeutics
CORT
$12.4B
| $667K | ﹤0.01% |
59,800
-41,600
| -41% | -$464K |
|
6162
CALL
Inspire Medical Systems
INSP
$1.65B
| $667K | ﹤0.01% |
+11,000
| New | +$593K |
|
6163
Qualys
QLYS
$6.44B
| $667K | ﹤0.01% |
7,664
+4,193
| +121% | +$362K |
|
6164
CALL
Lindsay Corp
LNN
$1.17B
| $666K | ﹤0.01% |
8,100
-3,000
| -27% | -$251K |
|
6165
QuidelOrtho
QDEL
$981M
| $666K | ﹤0.01% |
11,227
-59,884
| -84% | -$3.59M |
|
6166
PUT
Tenaris
TS
$27B
| $666K | ﹤0.01% |
25,300
-9,000
| -26% | -$241K |
|
6167
Aurinia Pharmaceuticals
AUPH
$2.06B
| $665K | ﹤0.01% |
101,047
-35,474
| -26% | -$226K |
|
6168
iShares Emerging Markets Infrastructure ETF
EMIF
$12.6M
| $665K | ﹤0.01% |
22,955
-920
| -4% | -$25.9K |
|
6169
CALL
Herc Holdings
HRI
$5.8B
| $665K | ﹤0.01% |
14,500
+100
| +0.7% | +$4.16K |
|
6170
CALL
Smith & Wesson
SWBI
$643M
| $665K | ﹤0.01% |
96,014
-5,074
| -5% | -$35.9K |
|
|
NBEV
6171
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $665K | ﹤0.01% |
142,751
-68,299
| -32% | -$350K |
|
6172
CALL
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $663K | ﹤0.01% |
25,600
-59,600
| -70% | -$1.54M |
|
6173
Shinhan Financial Group
SHG
$35.4B
| $663K | ﹤0.01% |
17,049
+10,302
| +153% | +$399K |
|
6174
Integer Holdings
ITGR
$4.26B
| $662K | ﹤0.01% |
7,891
-137,118
| -95% | -$10.3M |
|
6175
PUT
MacroGenics
MGNX
$269M
| $662K | ﹤0.01% |
39,000
+26,500
| +212% | +$455K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.